CAMP4 Therapeutics Corp. (CAMP)
4.45
-0.01
(-0.22%)
USD |
NASDAQ |
May 11, 16:00
4.45
0.00 (0.00%)
After-Hours: 17:32
CAMP4 Therapeutics Enterprise Value : 133.77M for May 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Viridian Therapeutics, Inc. | 1.133B |
| Tyra Biosciences, Inc. | 1.599B |
| Entrada Therapeutics, Inc. | 60.42M |
| Fate Therapeutics, Inc. | 152.06M |
| Praxis Precision Medicines, Inc. | 8.415B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.33M |
| Revenue (Quarterly) | 1.294M |
| Total Expenses (Quarterly) | 19.62M |
| EPS Diluted (Quarterly) | -0.3165 |
| Gross Profit Margin (Quarterly) | 59.81% |
| Profit Margin (Quarterly) | -1.42K% |
| Earnings Yield | -51.03% |
| Normalized Earnings Yield | -39.53 |